It remains unclear how mutations in FUS, a ribonucleoprotein, lead to neuronal dysfunction in Amyotrophic Lateral Sclerosis (ALS) patients. To examine mechanisms underlying ALS FUS dysfunction, we generated the first C. elegans knock-in models using CRISPR/Cas9mediated genome editing, creating R524S and P525L ALS FUS models. Although FUS inclusions were not detected, ALS FUS animals showed defective neuromuscular function, as well as stressinduced locomotion defects. Unlike C. elegans lacking the endogenous FUS ortholog, ALS FUS animals had impaired neuronal autophagy and increased SQST-1 accumulation in ALS FUS motor neurons. Loss of sqst-1, the C. elegans ortholog for ALS-linked, autophagy adaptor protein SQSTM1/p62, suppressed both neuromuscular and stress-induced locomotion defects in ALS FUS animals, but did not suppress neuronal autophagy defects. Therefore, autophagy dysfunction is upstream of, and not dependent on, SQSTM1 function in ALS FUS pathogenesis.
Introduction
Amyotrophic Lateral Sclerosis (ALS) is an incurable adult-onset neurodegenerative disease characterized by progressive neuromuscular denervation and motor neuron loss.
Mutations in FUsed in Sarcoma (FUS) account for approximately 5% and 1% of familial and sporadic ALS cases, respectively [1] . FUS is an DNA/RNA binding protein that participates in transcription, splicing and mRNA stabilization in the nucleus, and contributes to stress granule formation, axonal transport and microRNA function in the cytoplasm [2] . Most disease-linked FUS mutations map to the FUS C-terminal nuclear localization signal (NLS), leading to cytoplasmic FUS mislocalization and aggregation in patient motor neurons [3] . Cytoplasmic FUS aggregates are also seen in patients with Frontotemporal Dementia (FTD) [4] . FUS overexpression in mice leads to dose-dependent neuromuscular defects and neurodegeneration reminiscent of ALS, with altered RNA transcription and splicing in motor neurons [2] . FUS overexpression impairs synaptic function in mice, flies and nematodes [5] [6] [7] [8] [9] [10] [11] . Furthermore, in fly and mouse ALS FUS overexpression models, neuromuscular dysfunction precedes motor neuron degeneration [12, 13] , suggesting synaptic dysfunction is an early event in ALS pathogenesis. These over/misexpression models demonstrate that FUS protein perturbation is deleterious for neuronal function and survival. However, molecular changes that occur before symptom onset remain elusive. ALS FUS knock-in model in mice showed neuronal dysfunction and degeneration in the absence of cytoplasmic FUS protein accumulation, suggesting aggregates may not be the initial drivers of neuronal dysfunction in neurons [14] .
Studying early changes in ALS FUS may yield insight into disease mechanisms. Defective autophagy likely contributes to neuronal dysfunction in neurodegenerative diseases, as evidenced by ALS-linked mutations in autophagy-related genes SQSTM1/p62 [15] , UBQLN2 [16] , VCP [17] , OPTN [12, 18, 19] and TBK1 [5] . Autophagy is a catabolic pathway that delivers membrane-enclosed proteins and organelles to lysosomes. Essential autophagy-mediated cellular functions include protein turnover, misfolded/aggregation-prone protein degradation, and metabolic stress adaptation [20] . Autophagy adaptor protein SQSTM1 accumulates in ALS patient motor neurons [21] , which may indicate autophagy dysfunction. Consistent with this, LC3-positive autophagy vesicles are elevated in ALS FUS patient motor neurons [22, 23] . Thus, autophagy dysfunction may contribute to ALS disease pathogenesis.
Studies in FUS overexpression models have revealed autophagy dysfunction. FUS overexpression perturbs autophagy flux in neuronal cell lines transfected with wild type or mutant FUS [11, 23] . Wild type FUS overexpression alters RNA processing, upregulates lysosomal genes, and leads to improper SQSTM1 accumulation in transgenic mice [11] . Combined, these findings suggest that improper FUS levels negatively impact autophagy. However, it remains unclear if ALS-linked FUS mutations per se impact neuronal autophagy at early stages of pathogenesis.
Here, we generated the first ALS FUS knock-in models in C. elegans. Using CRISPR/Cas9-mediated homologous recombination, we inserted the equivalent patient mutations for R524S and P525L into the C. elegans FUS orthologous gene, fust-1. Animals carrying these knock-in alleles were hypersensitive to stress and had impaired neuromuscular function. Importantly, FUS knock-in mutations differentially impaired neuronal and muscular autophagy, while leaving the neuronal ubiquitin proteasome system intact. Loss of function in the SQSTM1 ortholog, sqst-1, suppressed stress-induced locomotion defects and aldicarb sensitivity in ALS FUS animals.. However, loss of SQSTM1/sqst-1 function did not suppress neuronal autophagy defects in ALS FUS animals, despite the restoration of normal locomotion and aldicarb sensitivity. Our findings in new C. elegans ALS FUS knock-in models complement ALS FUS overexpression models and suggest autophagy dysfunction contributes to ALS FUS pathogenesis.
Results

ALS FUST-1 protein mislocalizes to the cytoplasm in C. elegans motor neurons
At steady state levels, wild type FUS protein localizes primarily to the nucleus. ALS-linked FUS mutations R524S and P525L disrupt nuclear FUS localization and lead to cytoplasmic FUS aggregation [22] . We examined whether the introduction of equivalent nuclear localization signal (NLS) mutations would disrupt subcellular localization of FUST-1 protein, the C. elegans ortholog for FUS ( Figure 1A) . The R524S and P525L equivalent point mutations in the C. elegans FUST-1 protein are R446S and P447L, respectively. Note that C. elegans fust-1 alleles generated herein will be referred to with amino acid numbering in the orthologous human FUS protein.
Transgenes expressing C. elegans FUST-1 protein with an N-terminal GFP fusion tag (GFP::FUST-1) were used to determine the nuclear-to-cytoplasmic ratio of GFP::FUST-1 in C. elegans motor neurons ( Figure 1B) . For this analysis, animals were mechanically immobilized with microbeads and GFP::FUST-1 fluorescence was measured in five cholinergic motor neurons (VA10, VB11, DB7, AS10 and DA7). As expected [24] , wild type C. elegans GFP::FUST-1 localized predominantly to the nucleus, while GFP::FUST-1 R524S and P525L proteins showed cytoplasmic displacement ( Figure 1C) . We calculated the nuclear index of GFP fluorescence for each reporter (Figure 1D) . The predominantly nuclear GFP::FUST-1WT protein had a nuclear index of 0.9 ± 0.02 per neuron ( Figure 1E) . By contrast, GFP::FUST-1 R524S and P525L proteins had nuclear indices of 0.21 ± 0.02 and -0.12 ± 0.02, respectively, consistent with cytoplasmic displacement (Figure 1E, Figures S2 A and B) . We conclude that the nuclear localization of C.
elegans FUST-1 protein in motor neurons is disturbed when ALS-causal mutations are inserted, replicating localization changes seen in FUS ALS patient motor neurons.
In patient motor neurons, FUS mutations lead to cytoplasmic FUS deposits [2] . By contrast, live transgenic C. elegans immobilized with microbeads showed diffuse cytoplasmic GFP::FUST-1R24S and GFP::FUST-1P525L fluorescence in motor neurons. However, when animals were briefly immobilized with 2,3-butanedione monoxime (BDM) or sodium azide (NaN3), GFP::FUST-1 formed inclusions in motor neurons (Figure S2 C) . These chemicals are frequently used to anesthetize C. elegans, but they induce metabolic [25] or mitochondrial stress [26] , respectively. Thus, stress may drive formation of cytoplasmic GFP-FUST-1 inclusions. To confirm, we treated animals with dithiothreitol (DTT) to induce endoplasmic reticulum (ER) stress [27] . Brief DTT exposure induced cytoplasmic FUST-1 inclusions in motor neurons expressing the R524S and P525L GFP:FUST-1 proteins, but not in animals overexpressing wild type GFP::FUST-1 (Figure S2 D and E) . Consistent with observations in other systems, our results suggest that stress drives formation of FUS inclusions [9, 24] .
Generation of C. elegans knock-in ALS fust-1 models
To generate C. elegans ALS FUS knock-in models, we used template-driven, CRISPR/Cas9-mediated genome editing to insert R524S and P525L equivalent mutations into the C-terminal NLS of the endogenous fust-1 gene on chromosome II (Figure 2A) . Because genome editing requires introduction of silent codon changes, we generated a wild type control strain containing silent mutations ( Figure 2B) . A "C" superscript (fust-1WT C , fust-1R524S C , and fust-1P525L C ) is used to distinguish the edited alleles from the control, non-transgenic fust-1(+) allele found in the standard laboratory C. elegans strain (N2). We refer to fust-1R524S C and fust-1P525L C animals together as ALS fust-1 animals.
FUS overexpression leads to severe locomotion defects [9, 12, 13, 28] . ALS fust-1 knock-in animals had no overt locomotion defects on solid surfaces, or detectable swimming defects on day 1 or on day 10 of adulthood (Figure 2F-I and Figure S3 A, using CeleST [29] ). In addition, C. elegans FUS knock-in models had normal life spans (Figure 2C) , pharyngeal feeding (Figure   S3 B) , and no neuron loss was observed.
Knock-in animals are hypersensitive to stress and have stress-induced locomotion defects
We have previously shown that stress reveals latent defects in C. elegans knock-in models for ALS SOD1 [30] . ALS FUS mutations may also impair cellular stress responses [24, 31, 32] [30] .
To identify latent defects in ALS FUS animals, we examined the impact of DTT-induced ER stress [27] and juglone-induced oxidative stress [33] . ALS fust-1 animals had decreased survival after stress, compared to fust-1WT C controls. To examine if loss of fust-1 function contributes to stress sensitivity, we examined stress response in fust-1(tm4439) loss of function animals [34] , referred to as fust-1(-) animals. Loss of fust-1 sensitized animals to DTT, but not to juglone (Figure S3 C) .
Thus, loss of fust-1 function may contribute to the ER stress sensitivity, but not oxidative stress sensitivity, in ALS fust-1 knock-in models.
To reveal latent stress-induced defects, we tested swimming locomotion after DTTinduced ER stress (Figure 2F-I) . Swimming ALS fust-1 animals had impaired locomotion compared to fust-1WT C animals after a brief ER stress exposure ( Figure 2F -I, CeleST [29] ).
Combined, our analysis of ALS FUS animals shows that stress induces formation of FUST-1 inclusions within C. elegans motor neurons, and reveals latent survival and locomotion defects.
Knock-in animals show impaired autophagy in motor neurons and muscles, m
Recent evidence suggests that wild type FUS overexpression may impair neuronal autophagy [11] . However, it remains unclear whether ALS FUS mutations impair neuronal autophagy. To monitor autophagy, we used a tandem-tagged dual GFP::mCherry::LGG-1 reporter broadly expressed under the lgg-1 promoter [35] . LGG-1 is the C. elegans ortholog of mammalian Atg8, a component of autophagy membranes. Accumulation of the GFP::mCherry::LGG-1 reporter into autophagy membranes leads to formation of green+red fluorescent autophagosomes (APs) ( Figure 3A) . Fusion of green+red fluorescent APs with acidic lysosomes quenches pH-sensitive GFP fluorescence, resulting in red fluorescent autolysosomes (ALs) ( Figure 3A) . Finally, lysosomal enzymes degrade the GFP::mCherry::LGG-1 protein, abolishing all fluorescence.
As a control, we first examined neuronal autophagy in the motor neurons of atg-7(bp411) loss of function animals (Figure 3B and 3C) . atg-7 function is required early in autophagy [35] .
As predicted, loss of atg-7 function diminished the number of neuronal ALs compared to non-transgenic N2 animals ( Figure 3C ) [35] . We found that ALS fust-1 alleles increased APs and decreased ALs in motor neurons, compared to fust-1WT C controls. We confirmed neuronal autophagy defects in ALS fust-1 animals by rearing animals under different conditions and saw qualitatively similar autophagy defects (Figure S4 A-D) . Combined, these results suggest that neuronal autophagy activity is impaired in ALS fust-1 animals ( Figure 3D ).
Neuronal autophagy defects in ALS fust-1 animals were also quantified using a different
LGG LGG-1 protein levels by Western Blot permits the quantitation of neuronal autophagy flux [36] . We found that ALS fust-1 alleles decreased the relative ratio of neuronal mFP to fulllength dFP::
LGG-1, suggesting that neuronal autophagy flux is impaired in ALS fust-1 animals ALS fust-1 alleles could globally disrupt all major cellular catabolic pathways, including the ubiquitin proteasome system (UPS). However, we did not detect UPS defects in two different experimental paradigms ( Figure S7) . Thus, ALS fust-1 alleles specifically impair autophagy, while leaving the UPS intact.
Knock-in animals have impaired neuromuscular function
Neuromuscular dysfunction precedes motor neuron degeneration in ALS patient motor neurons [37] [38] [39] . To test for neuromuscular defects in ALS fust-1 knock-in models, we examined resistance to aldicarb, a pharmacological inhibitor of acetylcholinesterase [40] . Aldicarb exposure causes paralysis due to excessive cholinergic excitation at the neuromuscular junction (NMJ) and eventually leads to death ( Figure 4A ) [40] . Decreased synaptic release delays paralysis onset, while increased release can accelerate paralysis [40] . Notably, overexpression of ALS-linked human FUS delta57 in C. elegans GABAergic neurons causes aldicarb hypersensitivity [10] . We found that ALS FUS knock-in animals were also hypersensitive to aldicarb-induced paralysis and immobilized more quickly than fust-1WT C animals in the presence of 1mM aldicarb ( Figure 4B) .
No changes in NMJ protein localization were observed (Figure S8 A-D) . fust-1(-) animals were not markedly sensitive to aldicarb, although a trend toward hypersensitivity was noted ( Figure   4B ). We conclude that ALS FUS animals show impaired neuromuscular function.
Increased aldicarb sensitivity could also arise from alterations in muscular function, which we examined using levamisole resistance assay. Exposure to levamisole, a cholinergic receptor agonist, leads to paralysis due to excessive body wall muscle contraction (Figure S9 A) .
Mutations that impair muscular function or structure can alter responses to levamisole. ALS fust-1 animals were hypersensitive to levamisole compared to fust-1WT C animals, suggesting muscular function is also impaired in ALS FUS models (Figure S9 B) .
Loss of C. elegans SQSTM1 suppresses locomotion and neuromuscular function defects
in knock-in animals SQSTM1/p62 selectively recognizes and delivers cargo to autophagy membranes for degradation [41] . SQSTM1 accumulates in ALS FUS patient motor neurons and SQSTM1 mutations can cause ALS. We examined the impact of loss of sqst-1, the C. elegans SQSTM1 ortholog, on neuromuscular and locomotion defects in ALS fust-1 animals using the sqst-1(ok2892) loss of function allele. First, we examined aldicarb sensitivity in double-mutant animals.
Loss of sqst-1 function rescued aldicarb hypersensitivity in both fust-1R524S C and fust-1P525L C animals ( Figure 4C ). However, sqst-1 loss of function by itself had no impact on aldicarb resistance, suggesting sqst-1 function may be dispensable for neuromuscular function in wild type animals. Another sqst-1 loss of function allele partially rescued aldicarb hypersensitivity in fust-
We also examined stress-induced locomotion defects in double mutant animals. After DTT-induced ER stress, the locomotion defects in fust-1P525L C animals were partially suppressed by sqst-1 loss of function. (Figure 4C ). However, loss of sqst-1 function did not rescue levamisole hypersensitivity in ALS fust-1 animals (Figure S9 C) . Consequently, ALS fust-1 alleles may impair neuronal and muscular function via independent mechanisms.
Loss of C. elegans SQSTM1 does not restore mutant FUST-1 localization
Loss of C. elegans SQSTM1 ortholog might alleviate ALS fust-1 neuromuscular function defects by restoring nuclear fust-1 localization. We tested this hypothesis using transgenic animals expressing wild type or mutant C. elegans FUST-1 protein with an N-terminal GFP fusion tag (GFP::FUST-1) in sqst-1(ok2892) loss of function background. Loss of sqst-1 function did not restore mutant GFP::FUST-1 predominant nuclear localization in the motor neurons (Figure 5A-B ). And, loss of sqst-1 function did not alter nuclear localization of wild type FUST-1 protein ( Figure 5A-B) . Thus, loss of sqst-1 function does not suppress aldicarb response defects by correcting cytoplasmic mislocalization of the mutant FUST-1 protein in C. elegans motor neurons.
Loss of C. elegans SQSTM1 does not rescue neuronal autophagy flux
Alternatively, loss of the C. elegans SQSTM1 ortholog might alleviate ALS fust-1 neuromuscular function defects by restoring autophagy function. Thus, we wondered if ALS fust-1 alleles perturb neuronal autophagy in a sqst-1 dependent manner. To test this hypothesis, we examined APs and ALs labelled by the GFP::mCherry::
LGG-1 reporter in double-mutant animals carrying an ALS fust-1 mutation and the sqst-1(ok2892) loss of function allele. However, loss of sqst-1 function did not suppress ALS fust-1 autophagy defects in motor neurons (Figure 5C-E) .
Furthermore, loss of sqst-1 function alone in otherwise wild type animals had no impact on the APs or ALs in motor neurons (Figure 5C-E) . These results suggest that SQST-1 is dispensable for autophagy in C. elegans motor neurons. We conclude that ALS fust-1 alleles do not disrupt neuronal autophagy by perturbing SQST-1 function.
Exposure to aldicarb induces stress in C. elegans
The responses of ALS fust-1 animals to aldicarb suggests that this treatment might be stressful to C. elegans. To assess this, we examined the subcellular localization of DAF-16 FOXO transcription factor in wild type animals treated with aldicarb. Cellular stress leads to nuclear translocation DAF-16, driving transcription of stress response genes [42] . Aldicarb exposure increased the nuclear translocalization of DAF-16::GFP in the intestines of wild type animals compared to control animals, suggesting that aldicarb treatment is stressful for C. elegans ( Figure   6A ). Indeed, aldicarb treatment for four hours led to formation of GFP::FUST-1 neuronal inclusions (Figure S11 A and B) . We suggest that aldicarb exposure is stressful and may drive neuronal stress in ALS fust-1 animals.
SQST-1 accumulates specifically in motor neurons of ALS fust-1 animals after perturbations of neuromuscular function by aldicarb
SQSTM1/SQST-1 protein accumulates with age and stress [43] . Furthermore, FUS and SQSTM1 proteins co-aggregate in the motor neurons of ALS FUS patients, suggesting that mutant FUS protein leads to accumulation and/or aggregation of SQSTM1 in neurons. To test this hypothesis, we crossed a SQST-1::GFP reporter into fust-1WT C (Figure S11 C) . SQSTM1 is degraded through autophagy and improper SQSTM1 accumulation may indicate autophagy defects [42] .
Since loss of sqst-1 function suppresses neuromuscular defects, but not autophagy defects, we conclude that neuronal SQST-1 accumulation likely acts downstream of autophagy dysfunction in ALS fust-1 animals.
Exposure to aldicarb changes neuronal autophagy flux in C. elegans
The results above suggest that aldicarb treatment may exacerbate neuronal autophagy defects in ALS FUS animals. This drove us to ask if aldicarb treatment induces changes in neuronal autophagy of normal animals. We examined the GFP::mCherry::
LGG-1 reporter in motor neurons after 4 hours of aldicarb treatment. Aldicarb treatment of fust-1WT C animals elevated the steady state levels of APs and decreased ALs levels (Figure 6D-F) . By contrast, aldicarb treatment did not exacerbate apparent neuronal autophagy defects in fust-1P525L C animals compared to untreated fust-1P525L C controls (Figure 6D-F) , possibly due to a ceiling effect associated with the preexisting autophagy defects in fust-1P525L C animals. Thus, aldicarb treatment elicits stress responses and alters autophagy activity in C. elegans motor neurons.
Combined, our results suggest that cytoplasmic ALS fust-1 alleles impair basal autophagy in C. elegans motor neurons ( Figure 6G ). Since we did not observe the same autophagy defects in fust-1 loss of function animals, these defects are likely driven by a gain of toxic function in cytoplasmically mislocalized ALS FUST-1 protein. Furthermore, aldicarb-induced perturbations of neuromuscular function elicit a stress response, change neuronal autophagy, and cause disproportionate SQST-1 accumulation in ALS fust-1 animal motor neurons (Figure 6G) . Thus, stress reveals latent autophagy defects in the motor neurons of ALS fust-1 animals.
Discussion
Together, the ubiquitin proteasome and the autophagy-lysosome systems help maintain proteostasis by degrading proteins. Accumulation of ubiquitin and SQSTM1 positive inclusions in ALS FUS patient motor neurons suggests defective proteolysis contributes to pathogenesis [44] .
However, early processes that lead to aberrant protein localization and aggregation in ALS FUS patient motor neurons remain elusive. Here, we show that ALS FUS knock-in alleles in C. elegans perturb basal neuronal autophagy, while leaving the ubiquitin proteasome system (UPS) intact.
Furthermore, loss of function in SQSTM1 ortholog sqst-1, an ALS-associated autophagy adaptor protein, suppressed neuromuscular function defects and stress-induced locomotion defects in ALS FUS knock-in models. Our findings suggest a role for autophagy defects in ALS FUSmediated neuronal dysfunction.
Here, we found that ALS FUS knock-in mutations perturbed basal autophagy in C. elegans motor neurons. Visual inspection of GFP::mCherry::
LGG-1 reporter in ALS FUS model motor neurons showed induction of autophagosomes (APs) with a concurrent depletion in autolysosomes (ALs). Similarly, lysosomal degradation of a neuronal dFP::LGG-1 reporter was diminished in ALS FUS models. We conclude that neuronal autophagy is perturbed in ALS FUS knock-in animals. Consistent with this notion, a recent study found elevated numbers of LC3positive autophagosomes in ALS FUS patient motor neurons, independently corroborating autophagy dysfunction in ALS FUS pathogenesis [23] . Neuronal autophagy defects in ALS FUS knock-in animals do not fully mimic neuronal autophagy defects in early autophagy mutants suggesting that ALS fust-1 alleles may perturb different and/or additional steps in the autophagy pathway. While more research is necessary to better understand autophagy in motor neurons and the precise step(s) at which neuronal autophagy is perturbed in ALS FUS models, we suggest that autophagy dysfunction may contribute to early decline in protein homeostasis in ALS FUS pathogenesis.
ALS FUS knock-in alleles may have cell-type specific impacts on autophagy. As seen in C. elegans motor neurons, C. elegans muscles had increased APs in ALS FUS knock-in animals.
However, the number of ALs in muscles was not changed. Differences in neuronal and muscular autophagy in ALS FUS models may arise in part from tissue-specific variations in basal autophagy. Indeed, two previous studies showed marked differences in C. elegans neuronal and muscular autophagy [35, 36] .
Disease-associated mutations in FUST-1 lead to cytoplasmic FUST-1 mislocalization in C. elegans motor neurons [10, 14] . Therefore, ALS FUS knock-in alleles may perturb neuronal autophagy through cytoplasmic gain of function and/or nuclear loss of function in fust-1. However, we found that neuronal autophagy in fust-1 loss of function animals was largely intact. Combined, our findings suggest that a gain of toxic function causes defects in neuronal autophagy.
Consistent with this, overexpression of wild type FUS protein in neuronal cell lines alternately increases and decreases autophagosome and autolysosome levels, respectively [11] . In addition, transgenic mice overexpressing wild type FUS show SQSTM1 accumulation in motor neurons, suggesting autophagy dysfunction [11] . Combined, our results complement previous work in FUS overexpression models and suggest that a gain of toxic function in mutant FUS disrupts neuronal protein homeostasis. ALS patient motor neurons show cytoplasmic FUS inclusions by disease end stage [21] .
However, in C. elegans motor neurons, mutant FUST-1 proteins were diffusely mislocalized into the cytoplasm and did not form inclusions under standard culture conditions. Lack of cytoplasmic FUST-1 inclusions may speak to the relative young age of adult C. elegans compared to human patients, who accumulate cytoplasmic FUS inclusions in motor neurons after decades [21] . Still, our findings are consistent with other work that shows i) human ALS FUS protein overexpression in C. elegans neurons does not lead to inclusion formation in young adult animals [9] and ii) FUS inclusions are dispensable for neuronal dysfunction in an ALS-linked FUS knock-in model in mice [14] . Consequently, FUS mislocalization may be an early event in disease pathogenesis. We note that examined strains herein were not fixed prior to visualization, thus allowing for the observation of neuronal autophagy reporters in live, unstressed animals.
Synaptic dysfunction and denervation preceed neuron loss in ALS patients [38, 39, 45] .
Here, we assessed neuromuscular function in ALS FUS knock-in animals by examining response to aldicarb, an acetylcholinesterase inhibitor. ALS fust-1 animals, unlike fust-1 loss of function animals, were hypersensitive to aldicarb, consistent with a gain of toxic function in ALS fust-1 perturbing NMJ function. Notably, overexpression of ALS-linked human FUS delta57 in C.
elegans GABAergic neurons also leads to aldicarb hypersensitivity [10] . While our results support a gain of toxic function in ALS FUS, animals lacking fust-1 also showed modest, albeit not significant, hypersensitivity to aldicarb. Therefore, we hesitate to rule out a role for fust-1 loss of function in the neuromuscular dysfunction of ALS FUS knock-in models.
ALS-linked FUS differentially localizes to cytoplasmic stress granules after exposure to stress [46, 47] and may perturb cellular stress responses. Here, we found that ER stress led to formation of cytoplasmic FUST-1 inclusions in transgenic animals expressing mutant, but not wild type, FUST-1, suggesting that stress may reveal latent defects in ALS FUS knock-in animals.
Consistent with this, ER stress and oxidative stress decreased survival in C. elegans ALS FUS knock-in models and ER stress led to locomotion defects. ALS FUS knock-in animals are hypersensitive to aldicarb and aldicarb treatment induced nuclear translocation of FOXO transcription factor DAF-16 in the intestines of wild type animals.Therefore, we suggest that aldicarb treatment induces an organismal level stress response. Combined, our findings suggest that ALS FUS knock-in mutations sensitize animals to various stressors.
Our findings also suggest that neuronal autophagy changes as part of normal physiological responses to stress in wild type animals. Aldicarb modulates neuronal autophagy in wild type animals by increasing and decreasing AP and AL levels, respectively. It is unclear if these steady-state changes represent increased or decreased neuronal autophagy activity.
However, induction of APs and depletion of ALs suggests impediment of neuronal autophagy flux after aldicarb treatment. By comparison, aldicarb treatment failed to induce a similar response in ALS fust-1 knock-in animals. This may be due to a ceiling effect; ALS fust-1-induced neuronal autophagy defects are present even without aldicarb treatment. Aldicarb treatment also lead to inappropriate accumulation of SQST-1 in ALS fust-1 motor neurons. Since both SQSTM1 and SQSTM1-bound cargo are degraded primarily through autophagy, aldicarb treatment likely induces disproportionate SQST-1 accumulation in ALS fust-1 motor neurons due to enhanced defects in neuronal autophagy. We conclude that stress likely exacerbates ALS FUS-induced defects in protein homeostasis.
In patient motor neurons, FUS aggregates with SQSTM1. Furthermore, mutations in SQSTM1 have been linked to ALS [21] . Thus, FUS and SQSTM1 may share disease mechanisms [44] . Here, we also examined the impact of loss of function in SQSTM1 ortholog sqst-1 in ALS FUS knock-in models. Remarkably, loss of sqst-1 suppressed neuromuscular and ER stress- ALS fust-1 alleles R524S C and P525L C were introduced into the endogenous fust-1 locus on chromosome II using CRISPR/Cas9-mediated homologous recombination and pha-1(ts) coconversion as in [49] . The guide RNA construct pHA#823 pU6::fust-1::guide was injected at 50 ng/ul into temperature-sensitive GE24 (pha-1(e2123) III) animals with 50 ng/ul of Peft-3::Cas9, 50ng/ul of pJW1285 pha-1 sgRNA, 10 uM of 200mer sense pha-1(+) rescue oligo [49] and 10uM of a mutation specific single-stranded oligodeoxynucleotide listed in Table S1 . Silent codon changes were introduced to generate a PvuI restriction site, and to prevent the re-hybridization of guide RNAs with edited fust-1 alleles. A wild type fust-1WT C control containing silent mutations only was also generated. Putative recombinants among pha-1(+) rescued animals were screened for insertion events with PCR amplification using fust-1_scr_f and and fust-1_scr_r, followed by PvuI digestion. Isolated alleles were verified by sequencing and backcrossed four times. The endogenous pha-1 locus was PCR amplified and sequenced to verify the replacement of repaired pha-1 allele with wild type pha-1(+) in all strains.
Behavioral and survival assays
Survival: Animals reared under standard culture conditions at 20 o C and scored on alternating days starting from the first day of adulthood. FUDR was not used [50] . Aging animals were transferred to a new seeded plate every other day until all animals stopped laying eggs.
Animals unresponsive to touch were scored as dead. To score survival on dithiothreitol (DTT), 20 mM DTT (Thermo Fisher Scientific R086) plates were prepared the day before the assay. To score survival on 5-Hydroxy-1,4-naphthoquinone (juglone), fresh 300 uM juglone (Sigma Aldrich H47003) plates were prepared on the same day as the survival assay. In both DTT and juglone sensitivity assays, animals were scored every hour for survival until all animals became unresponsive to touch.
Pharyngeal feeding/pumping: Day 1 adults were transferred onto NGM plates seeded with 200 ul of fresh bacterial OP50 lawn and feeding was recorded for 10 seconds per animal. Videos were scored manually.
Swimming: Animals on day 1 and day 10 of adulthood were transferred into 60 ul of M9 pipetted onto a 1 mm diameter ring on a microscope slide. Swimming was recorded at 18 frames per second for 30 seconds. Videos were analyzed using CeleST [29] .
Aldicarb and levamisole resistance: Day 1 adults were transferred onto 1 mM aldicarb (Sigma-Aldrich 33386) or 0.4 mM Levamisole (Sigma L9756) NGM plates. Paralysis was scored every hour for 8 hours by sequential prodding twice to the tail and twice to the head with a platinum pick. Animals were scored as paralyzed if no movement or pharyngeal pumping was observed for 5 seconds after prodding. Paralyzed animals were censored and were not scored again for subsequent time points. Fractional paralysis over time was calculated and data was analyzed with GraphPad Prism (La Jolla, CA) using log-rank analysis to establish statistical significance.
Neuronal survival
Motor neuron survival was examined in transgenic animals on day 1 of adulthood using a cholinergic (cho-1::mCherry) neuronal marker. A full list of strains used in this study can be found in Table S2 . Day 
Synaptic puncta imaging
Day 1 adult animals were mounted on 2% (vol/vol) agar pads and paralyzed using 30 mg/mL 2-3-butanedione monoxime (BDM) (Sigma) in M9 buffer. Images were captured in zstacks from dorsal cord posterior to vulva with a 100x objective, using Zeiss Axio Imager ApoTome Microscope and AxioVision software v4.8. For synaptic puncta imaging, we used BDM rather than microbeads to immobilize animals, as mechanically immobilized animals contract their muscles during imaging, which changes synaptic puncta locations in consecutive z-stack images.
Data from at least three independent trials (n ≥ 19 animals in total/genotype for all groups) was analyzed. Puncta total intensity and linear density were quantified using the Punctaanalyser program in Matlab (v6.5; Mathworks, Inc., Natick, MA, USA; RRID:SCR_001622). 
Quantification of subcellular GFP::FUST-1 localization and inclusions
Quantification of SQST-1 accumulations by microscopy
A sqst-1::GFP fusion reporter driven under the C. elegans sqst-1 promoter was used to visualize SQST-1 accumulation in motor neurons. Cholinergic motor neurons along the ventral nerve cord were visualized with a cholinergic Pcho-1::mCherry::NLS neuronal marker. To determine the number of motor neurons with SQST-1 accumulations, we scored 20 cholinergic motor neurons posterior to vulva in day 1 adult animals mechanically immobilized on microspheres as described above. SQSTM1 accumulations were scored under normal culture conditions, after 1 mM aldicarb treatment for one, two, four or six hours, and after 0.4 mM levamisole treatment for 4 hours. Motor neurons with SQSTM1 accumulations were manually scored at the microscope under a 40x objective (Zeiss AxioImager ApoTome and AxioVision software v4.8). The average and SEM were calculated and data was analyzed with GraphPad Prism (La Jolla, CA).
Autophagy by microscopy
To visualize autophagy activity in motor neurons, we used animals expressing the dualtagged GFP::mCherry::
LGG-1 reporter. Day 1 adults were mounted live with microspheres. The images were acquired with Olympus FV3000 Confocal Laser Scanning inverted microscope. GFP excitation and emission were set to 488 nm and 500-540 nm, respectively. mCherry excitation and emission were set to 561 nm and 570-670 nm, respectively. mCherry fluorescence intensity is greater and the gain of red channel was set lower to avoid overexposure, as previously described by Chang et al. [35] . Consequently, the cytoplasmic GFP::mCherry::LGG-1 reporter appears green in the images. Ventral cord motor neurons were identified based on location and morphology. Z-stack images of the motor neurons were acquired at 60x using 0.34 um steps over a vertical distance of 9.52 um. Green+red and red-only punctae were manually counted in the ventral nerve cord motor neurons in one 0.34 um slice where the neuronal nuclei could be observed. To visualize autophagic activity in body wall muscles, transgenic animals expressing the dual-tagged GFP::mCherry::LGG-1 reporter were similarly immobilized on day 1 of adulthood.
Z-stack images of body wall muscles were acquired at 60x using 0.34 um steps over a vertical distance of 9.52 um. Green+red and red-only punctae were manually counted in body wall muscles in one 0.34 um slice immediately below the slice with muscle filaments. The average and SEM were calculated, and data was analyzed with GraphPad Prism (La Jolla, CA).
In an independent set of experiments, we confirmed neuronal autophagy defects. Animals were raised on bacteria expressing double-stranded RNA against GFP and squat-1 (a.k.a. sqt-1) on NGM plates prepared with 100 ug/ml ampicillin and 6 mM isopropyl β-D-1thiogalactopyranoside (IPTG). L4 stage animals were passaged onto RNAi plates seeded with 200 ul of 10X concentrated bacterial strains L4417 and B0491.2 [51] to drive IPTG-induced RNAi against GFP and sqt-1, respectively. While feeding RNAi induces downregulation of respective genes in non-neuronal tissues, C. elegans neurons are resistant to feeding RNAi [52] . Thus, feeding RNAi disproportionately increased the GFP::mCherry::
LGG-1 reporter signal-to-noise ratio in motor neurons (Figure S4) . Feeding RNAi against sqt-1 partially suppressed the rolling phenotype in dual-tagged GFP::mCherry::
LGG-1 reporter lines, facilitating inspection of motor neurons After four days on RNAi plates, L4 stage progeny were transferred onto fresh RNAi plates. The next day, animals on day 1 of adulthood were tested for autophagy activity in neurons.
All bacterial clones were verified by sequencing.
Neuronal autophagy by Western Blot
To assess neuronal autophagy flux by Western Blot, we integrated a tandem-tagged neuronal LGG-1 dual fluorescent reporter (strain DLM11 from [36] ) and crossed it into ALS fust-1 models. To synchronize different genetic populations, 100 gravid adults were allowed to lay eggs for 5 hours at 20 o C on large 60 ml NGM plates seeded with 2.4 ml of OP50. At the end of 5 hours, gravid adults were removed from the plates and progeny were grown at 20 o C for 55 hours. LGG-1 (top). Lysosomal hydrolases cleave the sequence between mFPs. Ratio of mFP to dFP::
LGG-1 protein levels measures autophagy [36] . Middle: representative Westerns for dFP::
LGG-1, mFP and actin from ALS fust-1 and fust-1WT C control animals, after overnight chloroquine treatment. Chloroquine inhibits lysosomal activity [36] , allowing for visualization of neuronal mFP proteins in autolysosomes. Without chloroquine treatment, the mFP protein band was invisible. Bottom: neuronal mFP/dFP::
LGG-1 protein ratio normalized against fust-1WT C controls. ALS fust-1 alleles decrease mFP/dFP::
LGG-1 ratio compared to fust-1WT C controls. Three independent trials.
Error bars indicate -± SEM. Pairwise t-test: * p < 0.05; *** p < 0.001. Results in 3C and D were collected at the same time as the data presented in Figure 5D and E, and are from the same fust-1(+), fust-1WT C , fust-1R524S C and fust- Four hours of aldicarb exposure increased autophagosome (AP) levels and decreased autolysosome levels (AL) in control fust-1WT C animals. Without aldicarb, fust-1P525L C animals showed increased AP levels and decreased AL levels (also Figure 3B-D) . After aldicarb exposure, AP and AL levels did not substantively change. N > 46 animals per genotype. Pairwise t-test: * p < 0.05; ** p < 0.01; *** p < 0.001. (G) Summary. Top: mutant FUST-1 diffusely mislocalizes into the cytoplasm under standard culture conditions, and a gain of toxic function mechanism disrupts basal neuronal autophagy. Bottom: Under stressful conditions, mutant FUST-1 forms cytoplasmic inclusions and induces improper SQST-1 accumulation.
